overeating semaglutide on Wegovy: Effects, Safety, and What to Do GLP-1s, Obesity, Emotional Eating, and

[DOI] [PubMed] [Google Scholar] 35.Quoyer J., Longuet C., Broca C., Linck N., Costes S., Varin E., Bockaert J., Bertrand G., Dalle S

Oral semaglutide is a daily tablet formulation of the GLP-1 (glucagon-like peptide-1) receptor agonist

All of these potentially overlap with the side effects of semaglutide

Indications and mechanism of action As described by Liu, GLP-1 pathophysiology involves multiple mechanisms of action that improve glucose control and promote weight loss, including enhanced insulin secretion, inhibited glucagon release, delayed gastric emptying, increased satiety, and improved insulin sensitivity

The science says otherwise

GLP products face insurance coverage barriers In Wisconsin, about 1.6 million adults are living with obesity, according to the American Diabetes Association, and more than 400,000 people are living with diabetes